SEC Form 4 · accession 0001209191-19-015149
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard E Greene Jr.
Director
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2019 | S | 1,200 | $63.11 | D | 48,800 | I | See Footnotes |
| Common StockF3,F2 | Feb 28, 2019 | S | 800 | $64.30 | D | 48,000 | I | See Footnotes |
| Common StockF4,F2 | Feb 28, 2019 | S | 5,600 | $65.68 | D | 42,400 | I | See Footnotes |
| Common StockF5,F2 | Feb 28, 2019 | S | 2,400 | $66.21 | D | 40,000 | I | See Footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.77 and $63.45.
- F2The securities are held by the Greene Family Trust.
- F3The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $63.95 and $64.55.
- F4The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $65.01 and $65.96.
- F5The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $66.03 and $66.53.